The clinical utility of gene expression assays in breast cancer patients with 0-3 involved lymph nodes

被引：6

作者：

Barbi, Mali ^{[2
]}

Makower, Della ^{[1
]}

Sparano, Joseph A. ^{[3
]}

机构：

[1] Montefiore Med Ctr, Dept Oncol, 1695 Eastchester Rd, Bronx, NY 10461 USA

[2] Montefiore Einstein Ctr Canc Care, Bronx, NY USA

[3] Mt Sinai Sch Med, Div Hematol Oncol, New York, NY USA

来源：

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 2021年 / 13卷

关键词：

breast cancer; chemotherapy; gene expression profiling; hormone receptor-positive breast cancer; hormone therapy; 21-GENE RECURRENCE SCORE; ADJUVANT SYSTEMIC THERAPY; DISTANT RECURRENCE; POSTMENOPAUSAL PATIENTS; AMERICAN SOCIETY; GUIDE DECISIONS; PAM50; RISK; INDEX; PREDICTION; BENEFIT;

D O I：

10.1177/17588359211038467

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Multigene expression assays are prognostic for recurrence in hormone-receptor positive 2 (HER-2) negative breast cancer, and, in some cases, predictive of benefit from chemotherapy or extended endocrine therapy. The results of these assays may be used to guide treatment recommendations for early HER-2 negative breast cancer. We review the results of trials establishing the clinical utility of several commercially available gene expression assays.

引用

页数：14

共 50 条

[41] Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients
Gaurav Chatterjee
Trupti Pai
Thomas Hardiman
Kelly Avery-Kiejda
Rodney J. Scott
Jo Spencer
Sarah E. Pinder
Anita Grigoriadis
Breast Cancer Research, 20
[42] Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients
Chatterjee, Gaurav
Pai, Trupti
Hardiman, Thomas
Avery-Kiejda, Kelly
Scott, Rodney J.
Spencer, Jo
Pinder, Sarah E.
Grigoriadis, Anita
BREAST CANCER RESEARCH, 2018, 20
[43] Gene Promoter Hypermethylation in Tumors and Matched Affected Lymph Nodes of Breast Cancer Patients.
Van der Auwera, I
Renard, I
Van den Eynden, G.
Limame, R.
Trinh, X. B.
van Dam, P.
Van Marck, E.
Van Laere, S.
Vermeulen, P.
Dirix, L.
CANCER RESEARCH, 2009, 69 (24) : 586S - 586S
[44] Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Christoph Tausch
Susanne Taucher
Peter Dubsky
Michael Seifert
Roland Reitsamer
Werner Kwasny
Raimund Jakesz
Florian Fitzal
Lidija Filipcic
Michael Fridrik
Richard Greil
Michael Gnant
Annals of Surgical Oncology, 2012, 19 : 1808 - 1817
[45] Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Tausch, Christoph
Taucher, Susanne
Dubsky, Peter
Seifert, Michael
Reitsamer, Roland
Kwasny, Werner
Jakesz, Raimund
Fitzal, Florian
Filipcic, Lidija
Fridrik, Michael
Greil, Richard
Gnant, Michael
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (06) : 1808 - 1817
[46] Irradiation of Lymphatic Drainage Paths in Patients with early Breast Cancer and 0-3 Lymph Node Metastases Analysis of MA.20-Study
Krug, David
STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (11) : 889 - 891
[47] Joseph Sparano on Gene Expression Assays for Breast Cancer
Sparano, Joseph
ONCOLOGY-NEW YORK, 2011, 25 (10): : 947 - 947
[48] HYPERPLASTIC LYMPH-NODES SURROUNDING TUMOR AND INVOLVED LYMPH-NODES IN BREAST-CANCER - HAVE THEY A PARTICULAR SIGNIFICANCE
BERTRAND, FJ
PECKING, AP
MURRAY, JH
DEJAGER, R
LOKIEC, FM
FLOIRAS, JL
HANNA, MG
LYMPHOLOGY, 1994, 27 : 404 - 407
[49] Patients with Breast cancer and 1-3 Lymph nodes: role of Supraclavicular irradiation
Meyer, A.
Biancosino, A.
Karstens, J. H.
Biancosino, C.
Bremer, M.
STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 64 - 64
[50] Comparing the performance of gene expression assays in breast cancer
Suthers, Graeme K.
INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (04) : 1162 - 1162

← 1 2 3 4 5 →